Celltrion partners with US pharmacy chain for Yuflyma sales
Celltrion Healthcare, Celltrion's distribution unit, said Monday it has signed a deal with US specialty pharmacy chain CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the US market.
CarePartners Pharmacy is a national pharmacy that distributes medications across all 50 states and Washington DC, focusing on several niche programs, including autoimmune therapies.
Under the contract, Yuflyma will be distributed to drug stores operated by CarePartners Pharmacy nationwide, starting from the end of this month.
Celltrion said the partnership is expected to raise the presence of the Yuflyma autoimmune disease biosimilar among over 10 million patients in the US.
Yuflyma will be the only adalimumab sold at CarePartners Pharmacy drugstores as the US partner has decided not to sell AbbVie's blockbuster drug Humira and other competing biosimilars in the market.
Celltrion said it could ink the exclusive contract due to the drug's convenience both for patients and health care providers.
“Yuflyma uses a high concentration, citrate-free formulation, causing less pain when injected. The medication also comes with a latex-free injectable device, which can reduce allergy risk,” an official from Celltrion said.
Meanwhile, Celltrion Healthcare said the company will tap pharmacy benefit managers (PBMs), including Optum, to enlist Yuflyma in their formulary lists.
PBMs are companies that manage prescription drug benefits on behalf of health insurers. They negotiate fees and rebates with drug providers and create formulary lists of medications covered by insurance and reimburse pharmacies for patients' prescriptions.
Celltrion Healthcare said the company will increase its marketing efforts, with a goal of capturing around 40 percent share in the PBM market for adalimumab by the end of this year.
(责任编辑:패션)
下一篇:Supporters of Israel hold rally in Seoul, urge Hamas to stop atrocities
- ·Outpaced by Coupang, Shinsegae carries out major leadership reshuffle
- ·Mirae Asset continues to lead domestic equity ETF market
- ·Russian top diplomat to visit NK, accuses US of fueling tensions on Korean Peninsula
- ·PM to meet with Xi on sidelines of Asian Games in Hangzhou
- ·Dodgers prospect trying to fit in with S. Korean nat'l baseball team
- ·Foreign workers' deaths get weak sanctions
- ·US strategic bomber B
- ·Enjoying Halloween in Itaewon sparks debate online
- ·[view] 민심 더 싸늘해지는데…감동 없는 김기현 2기
- ·One Store attracts W20b from Krafton
- ·윤 대통령 “국민소통·현장소통·당정소통 강화하라”
- ·오세훈, ‘TBS 폐지’ 묻자 “그런 일 생겨서는 안 돼”
- ·One Store attracts W20b from Krafton
- ·[Contribution] Why hope matters in climate crisis
- ·Beef prices have soared 100
- ·Over 1,300 rescue workers still traumatized by Itaewon Halloween tragedy
- ·Beef prices have soared 100
- ·Gimbap and hanja cramming: Life of Korean Studies students in Paris
- ·[Korea Beyond Korea] In Paris, soaring demand for Korean studies yet to be fully met
- ·'Apgujeong Box Girl' sparks online debate
- ·Import prices up for 3rd month in September on higher oil prices
- ·TvN Sports, CGV to screen Bundesliga’s first ‘Korean derby’
- ·Yoon, doctors set to clash over medical school quota
- ·Another suspect of Tajik duo behind S. Korean money exchange robbery nabbed
- ·탄약 찾는 러…국방부 "北컨테이너 적재량, 포탄 수십만발 분량"